Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kochetkova, U. Maistrovskay, K. Buria, R. Kessler, G. Massard (Vladivostok, Russian Federation; Strasbourg, France). Circulating vascular endothelial growth factor and osteoporosis in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 565

Member's Comments

No comment yet.

Related content which might interest you: Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Vascular endothelial growth factor levels in active pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 610s Year: 2002 Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Serum levels of vascular endothelial growth factor in the differential diagnosis of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002 Vascular endothelial growth factor and oxidative stress in patients with primary lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 A role for vascular endothelial growth factor (VEGF) in fibrosis? Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Vascular endothelial growth factor and tumor necrosis factor gene polymorphisms in Turkish patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Low plasma stem cell factor combined with high transforming growth factor-a identifies high-risk patients in pulmonary arterial hypertension Source: ERJ Open Res, 4 (4) 00035-2018; 10.1183/23120541.00035-2018 Year: 2018 Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003 Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis? Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012